Metlife (MET) Current Deferred Revenue (2020 - 2026)

Metlife's Current Deferred Revenue history runs 7 years deep, the most recent figure standing at $5.2 billion for Q1 2026.

• On a quarterly basis, Current Deferred Revenue rose 9.51% year-over-year to $5.2 billion in Q1 2026; TTM through Mar 2026 was $5.2 billion, a 9.51% increase from a year earlier, with the FY2025 full-year figure at $5.2 billion, up 11.37% from the prior year.
• Current Deferred Revenue held at $5.2 billion in Q1 2026 per MET's latest filing, from $5.2 billion in the prior quarter.
• Across five years, Current Deferred Revenue topped out at $5.2 billion in Q1 2026 and bottomed at $3.8 billion in Q1 2022.
• The 5-year median for Current Deferred Revenue is $4.6 billion (2024), against an average of $4.5 billion.
• Across the five-year window, Current Deferred Revenue gained 17.22% in 2023 and rose 2.16% in 2024, its largest moves.
• Year by year, Current Deferred Revenue stood at $4.1 billion in 2022, then rose by 10.5% to $4.5 billion in 2023, then climbed by 2.16% to $4.6 billion in 2024, then grew by 11.37% to $5.2 billion in 2025, then gained by 0.43% to $5.2 billion in 2026.
• Per Business Quant, the three latest MET Current Deferred Revenue figures stand at $5.2 billion (Q1 2026), $5.2 billion (Q4 2025), and $5.1 billion (Q3 2025).